– InDevR Inc., a leader in progressive analytical technologies, announced today that they have received 510(k) market clearance for their FluChip-8G Influenza A+B Assay from the United States Food and Drug Administration (FDA).... Read more »
Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that The Medicines and Healthcare products Regulatory Agency (MHRA) has approved... Read more »
Network Leaders Discuss Policy Solutions to Give Patients Provider Choice, Access The American Association of Nurse Practitioners (AANP) met in New Orleans, Louisiana to investigate the basic job nurture experts play in... Read more »